Conventional cancer treatments such as surgery, chemotherapy, and radiation therapy have limited or no selectivity toward cancer cells, causing short-term and long-term side effects . For instance, surgery and radiation therapy for prostate cancer increase the risk of urinary incontinence, erectile dysfunction, and intestinal complications . Likewise, breast cancer chemotherapy leads to premature menopause, which increases the risk of osteoporosis and impaired fertility . Current anticancer drugs present promiscuous cellular targeting and insufficient cellular drug uptake. In addition, cancer cells are susceptible to developing drug resistance against these agents through multiple mechanisms . These limitations decrease drug efficacy in advanced stages and increase the likelihood of metastatic disease. Therefore, new treatments and new drug delivery strategies that present greater selectivity towards cancer cells and evade the common mechanisms of multidrug resistance are sought after.